Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
Clinical trial NCT05577091 · RECRUITING
Trial details
- NCT number
- NCT05577091
- Sponsor
- Beijing Tiantan Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-30
- Primary completion
- 2024-11-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.